As far as we’re concerned, arsenic is a killer, but microbes living in a world with very little oxygen almost three billion years ago used arsenic to get energy.

University of Adelaide researchers have for the first time shown how much of a critical role the natural antioxidant selenium plays at the earliest stages of a woman's fertility.

Using the Australian Synchrotron, Melbourne researchers have revealed details of key steps in the process of programmed cell death, or apoptosis. Their findings will lead to the development of new ways to treat cancer and other diseases.

With 2014 proving to be another successful year for Australian Synchrotron researchers, the signs are promising for 2015.

Greetings to all our visitors so far this year! The Australian Synchrotron has hosted quite a few visits in recent months, and we’re looking forward to further stimulating discussions when the annual user meeting and new user symposium are held here in November.

The Australian Synchrotron Annual Report 2014 demonstrates how the unique properties of synchrotron light are catalysing the best in research and innovation: supporting Australian health and wellbeing, and linking with Australian industry.

A potential new drug being trialled in Melbourne could be a major advance for patients with chronic lymphocytic leukaemia that doesn’t respond adequately to currently available treatments.

The first of our new series of public presentations was a tasty demonstration of the impact of synchrotron science on food technology.

A fast, inexpensive, room-temperature process will enable scientists to pursue industrial exploitation of an ultraporous material with great potential for sensing, microelectronics, biomedics, optics and catalysis applications.

This process could provide a sustainable energy supply for the future, but commercial applications are hampered by the cost of platinum catalysts. An Australian-international research team may have found a better way.